PPC:ATHEXPublic Power Corporation S.A. Analysis
Data as of 2026-07-19 - not real-time
$29.11
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Pilgrim's Pride is trading below its long‑term moving averages, signaling a bearish backdrop, yet the MACD histogram has turned positive and the signal line has crossed, hinting at emerging bullish momentum.
The RSI sits comfortably in the mid‑50s, indicating the price is not overbought, while volume has been tapering and recent volatility remains elevated, underscoring a heightened risk environment.
Fundamentally, the stock is priced at a low price‑to‑earnings multiple and sits well beneath its discounted cash‑flow estimate, suggesting a clear undervaluation with upside potential. However, thin profit margins, negative free cash flow and a relatively high leverage profile temper enthusiasm, and the lack of a dividend eliminates income appeal.
The RSI sits comfortably in the mid‑50s, indicating the price is not overbought, while volume has been tapering and recent volatility remains elevated, underscoring a heightened risk environment.
Fundamentally, the stock is priced at a low price‑to‑earnings multiple and sits well beneath its discounted cash‑flow estimate, suggesting a clear undervaluation with upside potential. However, thin profit margins, negative free cash flow and a relatively high leverage profile temper enthusiasm, and the lack of a dividend eliminates income appeal.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish alignment of short‑term moving averages
- declining volume trend
- positive MACD histogram indicating early bullish shift
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- significant undervaluation versus DCF fair value
- low price‑to‑earnings multiple relative to peers
- potential earnings improvement as margins stabilize
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- stable consumer defensive demand for protein products
- strong return on equity indicating efficient capital use
- upside potential toward analyst price targets
Key Metrics & Analysis
Financial Health
Revenue Growth1.60%
Profit Margin4.78%
P/E Ratio7.8
ROE25.81%
ROA9.31%
Debt/Equity89.62
P/B Ratio1.9
Op. Cash Flow$1.4B
Free Cash Flow$-900115520
Technical Analysis
TrendBearish
RSI54.1
Support$26.50
Resistance$29.71
MA 20$28.14
MA 50$28.58
MA 200$36.05
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Fair Value$45.06
Target Price$33.56
Upside/Downside15.30%
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.10
Volatility42.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.